SCHEMBL16334841

SCHEMBL16334841

Nc1cnc(N2CCN(c3ncccn3)CC2)c(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
MAPT P10636 3/20 0.42
TP53 P04637 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
KDM4E B2RXH2 2/20 0.41
LMNA P02545 1/20 0.41
CYP3A4 P08684 1/20 0.40
GAA P10253 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40
CYP2C19 P33261 1/20 0.40
GRM4 Q14833 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16334608 0.84 ALDH1A1 (0.51) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL25841222 0.82 ALDH1A1 (0.44) ALDH1A1MAPTTP53SMN1; SMN2MEN1
SCHEMBL23580075 0.82 ALDH1A1 (0.49) ALDH1A1MAPTTP53SMN1; SMN2MEN1
SCHEMBL16245824 0.81 ALDH1A1 (0.42) ALDH1A1MAPTTP53SMN1; SMN2MEN1
SCHEMBL23625755 0.80 ALDH1A1 (0.51) ALDH1A1MAPTTP53SMN1; SMN2MEN1
SCHEMBL16333978 0.80 MAPT (0.50) ALDH1A1MAPTTP53SMN1; SMN2MEN1
SCHEMBL16245768 0.78 ALDH1A1 (0.51) ALDH1A1MAPTTP53SMN1; SMN2MEN1
SCHEMBL16245849 0.78 SMN1; SMN2 (0.45) MAPTTP53SMN1; SMN2GAA
SCHEMBL3544476 0.78 MAPT (0.54) MAPTTP53SMN1; SMN2KMT2AKDM4E
SCHEMBL16340023 0.76 KMT2A (0.51) ALDH1A1MAPTTP53SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014207508-A1 PYRIDYL COMPOUND SUITABLE FOR THE TREATMENT OF METABOLIC DISORDERS Piramal Enterprises Limited (IN) 2014-12-31 WO disclosed